Researchers recently published a study of how #efavirenz, commonly used to treat HIV/AIDS, may help treat #lungcancer. Read the study → https://t.co/VgfNGTSYYR #LungCancerAwareness #Fridayfacts https://t.co/bOP9Wkm4y2
#Efavirenz (EFV) Induces DNA Damage Response Pathway in Lung Cancer. Read the full study → https://t.co/VgfNGTSYYR #LungCancerAwareness #lungcancer https://t.co/lfEE8GCs93
RT @Oncotarget: The cover for Issue 41 of @Oncotarget features Figure 7, "IPA ATM-signaling pathway in (A) EFV treated MRC-5 and (B) A549 c…
RT @Oncotarget: The cover for Issue 41 of @Oncotarget features Figure 7, "IPA ATM-signaling pathway in (A) EFV treated MRC-5 and (B) A549 c…
RT @Oncotarget: The cover for Issue 41 of @Oncotarget features Figure 7, "IPA ATM-signaling pathway in (A) EFV treated MRC-5 and (B) A549 c…
The cover for Issue 41 of @Oncotarget features Figure 7, "IPA ATM-signaling pathway in (A) EFV treated MRC-5 and (B) A549 cells" https://t.co/VgfNGTSYYR https://t.co/RbjTtuHBIb via @ImpactJrnls @EurekAlert